These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14675743)

  • 21. Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls.
    Hoerst M; Weber-Fahr W; Tunc-Skarka N; Ruf M; Bohus M; Schmahl C; Ende G
    Arch Gen Psychiatry; 2010 Sep; 67(9):946-54. PubMed ID: 20603446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures.
    Stein DJ; Hollander E; DeCaria CM; Simeon D; Cohen L; Aronowitz B
    Biol Psychiatry; 1996 Sep; 40(6):508-13. PubMed ID: 8879471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH response to intravenous clonidine challenge: absence of relationship with behavioral irritability, aggression, or impulsivity in human subjects.
    Coccaro EF; Kavoussi RJ
    Psychiatry Res; 2010 Jul; 178(2):443-5. PubMed ID: 20483477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic overlap between attention-deficit/hyperactivity disorder and borderline personality disorder in women: the role of temperament and character traits.
    van Dijk FE; Lappenschaar M; Kan CC; Verkes RJ; Buitelaar JK
    Compr Psychiatry; 2012 Jan; 53(1):39-47. PubMed ID: 21511251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulsivity, defensive functioning, and borderline personality disorder.
    van Reekum R; Links PS; Mitton MJ; Fedorov C; Patrick J
    Can J Psychiatry; 1996 Mar; 41(2):81-4. PubMed ID: 8705967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine correlates of temperamental traits in humans.
    Gerra G; Zaimovic A; Timpano M; Zambelli U; Delsignore R; Brambilla F
    Psychoneuroendocrinology; 2000 Jul; 25(5):479-96. PubMed ID: 10818282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of affective instability and UPPS impulsivity in borderline personality disorder features.
    Tragesser SL; Robinson RJ
    J Pers Disord; 2009 Aug; 23(4):370-83. PubMed ID: 19663657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting borderline and antisocial personality disorder features in nonclinical subjects using measures of impulsivity and aggressiveness.
    Fossati A; Barratt ES; Carretta I; Leonardi B; Grazioli F; Maffei C
    Psychiatry Res; 2004 Feb; 125(2):161-70. PubMed ID: 15006439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbitofrontal dysfunction related to depressive symptomatology in subjects with borderline personality disorder.
    Díaz-Marsá M; Carrasco JL; López-Ibor M; Moratti S; Montes A; Ortiz T; López-Ibor JJ
    J Affect Disord; 2011 Nov; 134(1-3):410-5. PubMed ID: 21641654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The borderline diagnosis II: biology, genetics, and clinical course.
    Skodol AE; Siever LJ; Livesley WJ; Gunderson JG; Pfohl B; Widiger TA
    Biol Psychiatry; 2002 Jun; 51(12):951-63. PubMed ID: 12062878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The catechol o-methyltransferase (COMT) val(158)met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD).
    Wagner S; Baskaya O; Anicker NJ; Dahmen N; Lieb K; Tadić A
    Acta Psychiatr Scand; 2010 Aug; 122(2):110-7. PubMed ID: 19906087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depressive response to physostigmine challenge in borderline personality disorder patients.
    Steinberg BJ; Trestman R; Mitropoulou V; Serby M; Silverman J; Coccaro E; Weston S; de Vegvar M; Siever LJ
    Neuropsychopharmacology; 1997 Oct; 17(4):264-73. PubMed ID: 9326751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the suicidal behavior of adolescent inpatients with borderline personality disorder and major depression.
    Horesh N; Orbach I; Gothelf D; Efrati M; Apter A
    J Nerv Ment Dis; 2003 Sep; 191(9):582-8. PubMed ID: 14504567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-ratings of anger and hostility in borderline personality disorder.
    Gardner DL; Leibenluft E; O'Leary KM; Cowdry RW
    J Nerv Ment Dis; 1991 Mar; 179(3):157-61. PubMed ID: 1997664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of borderline personality disorder.
    Links PS; Mitton MJ; Steiner M
    Can J Psychiatry; 1993 May; 38(4):255-9. PubMed ID: 8518977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four factors of impulsivity differentiate antisocial and borderline personality disorders.
    DeShong HL; Kurtz JE
    J Pers Disord; 2013 Apr; 27(2):144-56. PubMed ID: 23514180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A negative relationship between ventral striatal loss anticipation response and impulsivity in borderline personality disorder.
    Herbort MC; Soch J; Wüstenberg T; Krauel K; Pujara M; Koenigs M; Gallinat J; Walter H; Roepke S; Schott BH
    Neuroimage Clin; 2016; 12():724-736. PubMed ID: 27766203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amygdala-prefrontal disconnection in borderline personality disorder.
    New AS; Hazlett EA; Buchsbaum MS; Goodman M; Mitelman SA; Newmark R; Trisdorfer R; Haznedar MM; Koenigsberg HW; Flory J; Siever LJ
    Neuropsychopharmacology; 2007 Jul; 32(7):1629-40. PubMed ID: 17203018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.